Skip to main content

Table 3 Hepatitis B virus surface (HBs) antibody positive rate according to the time between vaccination and the HBs antibody test

From: Comparison of hepatitis B vaccine efficacy in Japanese students: a retrospective study

Vaccine administration route

HBs antibody 2 or 5 months after vaccination

2 months

5 months

Total

Men

Women

Total

Men

Women

(+)

(−)

(+)

(−)

(+)

(−)

(+)

(−)

(+)

(−)

(+)

(−)

Bimmugen® subcutaneous

266

27

175

19

91

8

207

14

8

2

199

12

 Positive rate

90.8%

90.2%

91.9%*

93.7%

80.0%

94.3%*

Heptavax-II® subcutaneous

161

100

99

76

62

24

87

25

3

2

84

23

 Positive rate

61.7%

56.6%

72.1%

77.0%

60.0%

78.5%

Heptavax-II® intramuscular

104

19

76

17

28

2

116

8

3

1

113

7

 Positive rate

84.6%

81.7%

93.3%

93.5%

75.0%

94.2%

  1. *,†,‡There were no significant differences between 2 and 5 months after vaccination in all the groups (p > 0.05)